Loading...
XASX
ALQ
Market cap4.31bUSD
Apr 10, Last price  
14.45AUD
1D
0.07%
1Q
-7.67%
Jan 2017
139.24%
Name

ALS Ltd

Chart & Performance

D1W1MN
No data to show
P/E
543.05
P/S
2.85
EPS
0.03
Div Yield, %
1.36%
Shrs. gr., 5y
-0.09%
Rev. gr., 5y
8.14%
Revenues
2.46b
+8.00%
435,595,000522,654,000635,867,000761,030,000920,351,000825,533,0001,108,329,0001,405,609,0001,455,600,0001,503,400,0001,422,200,0001,364,900,0001,272,300,0001,446,900,0001,664,800,0001,831,900,0001,761,400,0002,108,500,0002,279,200,0002,461,600,000
Net income
13m
-95.57%
-418,00034,843,00059,066,00076,819,000106,209,00075,301,000132,354,000222,413,000227,300,000154,400,000-174,500,000-240,700,00081,600,00051,800,000153,800,000127,800,000172,600,000190,500,000291,200,00012,900,000
CFO
359m
-18.35%
30,041,00046,515,00058,096,00079,576,000166,745,00099,565,000158,842,000228,949,000247,300,000233,900,000215,200,000169,600,000175,300,000122,400,000218,800,000259,000,000265,800,000286,800,000439,900,000359,200,000
Dividend
Jun 12, 20240.196 AUD/sh
Earnings
May 19, 2025

Profile

ALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, North Africa, and the Americas. The company operates through three segments: Life Sciences, Commodities, and Industrial. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies in geochemistry, metallurgy, inspection, and coal quality streams. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides coal sampling, analysis and certification, formation evaluation, and related analytical testing services. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment also provides analytical testing data to assist consulting and engineering firms, industries, and governments. The Industrial segment offers diagnostic testing and engineering solutions for the energy, resources, transportation, and infrastructure sectors. This segment serves asset owners, operators, constructors, and equipment manufacturers in the power, petrochemical, mining, minerals processing, water, infrastructure, and transportation industries. The company was formerly known as Campbell Brothers Limited and changed its name to ALS Limited in August 2012. ALS Limited was founded in 1863 and is headquartered in Milton, Australia.
IPO date
Jul 18, 1952
Employees
19,085
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
2,461,600
8.00%
2,279,200
8.10%
Cost of revenue
2,991,500
1,427,800
Unusual Expense (Income)
NOPBT
(529,900)
851,400
NOPBT Margin
37.36%
Operating Taxes
106,300
114,400
Tax Rate
13.44%
NOPAT
(636,200)
737,000
Net income
12,900
-95.57%
291,200
52.86%
Dividends
(189,600)
(176,600)
Dividend yield
2.97%
2.94%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
317,700
179,500
Long-term debt
1,950,900
1,520,500
Deferred revenue
44,400
7,900
Other long-term liabilities
101,500
56,300
Net debt
1,922,600
1,226,900
Cash flow
Cash from operating activities
359,200
439,900
CAPEX
(151,700)
(146,100)
Cash from investing activities
(235,900)
(267,000)
Cash from financing activities
(3,100)
(121,200)
FCF
(668,700)
311,800
Balance
Cash
299,900
179,600
Long term investments
46,100
293,500
Excess cash
222,920
359,140
Stockholders' equity
1,196,900
1,378,200
Invested Capital
2,901,780
2,733,260
ROIC
30.28%
ROCE
27.33%
EV
Common stock shares outstanding
486,800
485,700
Price
13.13
6.23%
12.36
-7.76%
Market cap
6,391,684
6.47%
6,003,252
-7.23%
EV
8,327,884
7,241,452
EBITDA
(356,000)
1,003,900
EV/EBITDA
7.21
Interest
64,200
43,000
Interest/NOPBT
5.05%